Consultation recommendations Consultation recommendations 2018 2019 2020
Number of anti-infection recommendations n (%) Empirical application 25(18.0) 50(18.9) 56(17.1)
Drug use adjustment 60(43.2) 126(47.5) 153(46.6)
Whether to apply antibacterial drugs 6(4.3) 11(4.2) 23(7.0)
Whether to deactivate antibacterial drugs 3(2.2) 18(6.8) 22(6.7)
Preventive use 1(0.7) 1(0.4) 2(0.6)
Dosage adjustment 19(13.7) 18(6.8) 30(9.1)
Treatment course 7(5.0) 7(2.6) 9(2.7)
Other recommendations 18(12.9) 34(12.8) 33(10.1)
Total 139(100) 265(100) 328(100)
Number of anticoagulant recommendations n (%) Empirical application 2(16.7) 3(7.7) 12(14.5)
Drug use adjustment 1(8.3) 1(2.6) 5(6.0)
Dosage selection 2(16.7) 6(15.4) 7(8.4)
Treatment course 1(8.3) 1(2.6) 3(3.6)
Whether to apply anticoagulant drug 1(8.3) 8(20.5) 22(26.5)
Whether to deactivate antibacterial drug 3(25.0) 6(15.4) 7(8.4)
Physical method 1(8.3) 12(30.8) 24(28.9)
Other recommendations 1(8.3) 2(5.1) 3(3.6)
Total 12(100) 39(100) 83(100)
Number of PPIs application recommendations n (%) Whether to apply PPIs 1(8.3) 5(17.2) 13(25.0)
Choice of drugs 3(25.0) 8(27.6) 9(17.3)
Preventive use 4(33.3) 7(24.1) 16(30.8)
Dose adjustment 2(16.7) 7(24.1) 9(17.3)
Treatment course 1(8.3) 1(3.4) 1(1.9)
Other recommendations 1(8.3) 1(3.4) 4(7.7)
Total 12(100) 29(100) 52(100)
Number of nutritional support recommendations n (%) enteral 2(66.7) 17(81.0) 18(62.1)
parenteral 1(33.3) 4(19.0) 11(37.9)
Total 3(100) 21(100) 29(100)
Number of follow-up monitoring recommendations n (%) Liver and kidney function 32(25.8) 58(21.2) 90(21.7)
Coagulation index 6(4.8) 28(10.3) 62(15.0)
Infection index/signs 73(58.9) 136(49.8) 202(48.8)
Bleeding 2(1.6) 10(3.7) 29(7.0)
Nutrition improvement 3(2.4) 15(5.5) 19(4.6)
Adverse reactions 8(6.5) 26(9.5) 12(2.9)
Total 124(100) 273(100) 414(100)
Total(n) 290 627 906